Charles Schwab Investment Management Inc Roivant Sciences Ltd. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,120,785 shares of ROIV stock, worth $24.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,120,785

Previous 2,112,411 0.4%

Holding current value

$24.9 Million

Previous $22.3 Million 0.68%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$10.36 - $11.74 $86,754 - $98,310	8,374 Added 0.4%	2,120,785 $22.4 Million
Q1 2024 May 08, 2024	BUY	$9.87 - $11.8 $882,220 - $1.05 Million	89,384 Added 4.42%	2,112,411 $22.3 Million
Q4 2023 Feb 06, 2024	BUY	$8.38 - $11.58 $830,860 - $1.15 Million	99,148 Added 5.15%	2,023,027 $22.7 Million
Q3 2023 Nov 08, 2023	BUY	$9.76 - $13.19 $12.7 Million - $17.1 Million	1,297,134 Added 206.96%	1,923,879 $22.5 Million
Q2 2023 Aug 09, 2023	BUY	$7.09 - $10.08 $373,146 - $530,510	52,630 Added 9.17%	626,745 $6.32 Million
Q1 2023 May 11, 2023	BUY	$6.92 - $9.98 $91,454 - $131,895	13,216 Added 2.36%	574,115 $4.24 Million
Q4 2022 Feb 13, 2023	BUY	$3.36 - $7.99 $131,940 - $313,751	39,268 Added 7.53%	560,899 $4.48 Million
Q3 2022 Nov 14, 2022	SELL	$0.51 - $4.84 $97,705 - $927,247	-191,580 Reduced 26.86%	521,631 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$2.81 - $4.84 $29,120 - $50,156	-10,363 Reduced 1.43%	713,211 $2.9 Million
Q1 2022 May 13, 2022	BUY	$4.74 - $9.91 $154,021 - $322,015	32,494 Added 4.7%	723,574 $3.58 Million
Q4 2021 Feb 11, 2022	BUY	$5.86 - $13.52 $4.05 Million - $9.34 Million	691,080 New	691,080 $6.97 Million

Others Institutions Holding ROIV

# of Institutions

314

Shares Held

495M

Call Options Held

1.29M

Put Options Held

1.15M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.28B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Roivant Sciences Ltd. Transaction History